U.S. FDA Clears Stride's Italy Semi-Solids Production Plant For Imports
This article was originally published in PharmAsia News
Executive Summary
The new Italy plant of Strides Arcolab of India has been cleared by the U.S. FDA for producing semi-solid drugs importable into the U.S.